MondayMorning — Your News & Information Solution

MondayMorning is a weekly electronic newsletter providing a digest of breaking news that has a significant economic impact on the healthcare industry. A must for all top decision-makers and information managers, the service was founded in 1991, and weekly briefings contain approximately 30 articles spanning a wide range of news categories including economic, business, financial markets, scientific, clinical, technological, legal, legislative, and regulatory — both in the U.S. and internationally.

All industry sectors are covered by our editors, including pharmaceutical and biotechnology, medical device manufacturers, healthcare providers and HMOs, and healthcare financing authorities. Typical developments captured in each briefing are vital FDA and ECU action, late-breaking legislative and regulatory news, mergers and acquisitions, significant swings in stock prices, initial public offerings, crucial federal and state court decisions, advances in science and technology, and changes in the financing of healthcare.

Subscribe to MondayMorning.

Editors With Unparalleled Experience

What makes MondayMorning unique is that its news summaries furnish not just a synopsis of the facts behind a particular development, but its economic significance and impact in the opinion of the newsletter’s experienced editors. The staff is headed by founder and executive editor, Steve Walker.

Our News Sources

Monday Morning is derived from stories our editors are following, from press releases, news-wire services such as Dow Jones, Bloomberg and Associated Press, and a wide range of healthcare/medical, legal and financial journals such as JAMA, the New England Journal of Medicine, the Lancet, Nature, etc.

Our Clientele

The MondayMorning service is designed to offer information solutions to business professionals, and academic and trade researchers. The service is used by pharmaceutical and biotechnology companies; hospitals, healthcare systems and HMOs; medical-device companies; clinical and law-firm practices; medical and business schools; legislative and regulatory agencies, and academic and public libraries.

Subscribe to MondayMorning.


MondayMorning is published throughout the year except Memorial Day, the last two weeks of August, and Christmas. Please visit our subscription information page for details on pricing of our weekly email.

MondayMorning is published by MedContent, Inc. ISSN 1071-1368.

To contact us:

E-mail – editor [at] mondaymorning.com

Regular mail – MondayMorning
Post Office Box 172,
Cardiff, CA 92007

Phone – 760-807-4816 Mon-Fri, 9am-5pm Pacific Time.

Subscribe to MondayMorning.


MondayMorning is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MondayMorning are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.

MondayMorning makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in MondayMorning.com, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The reader of MondayMorning.com content assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in MondayMorning.com.

The content on any of MondayMorning websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options.

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice.

Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research.

To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice.

Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.

Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and MondayMorning, its partners, representatives and employees assume no responsibility or liability for any use or misuse of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Nothing herein constitutes a recommendation respecting the particular security mentioned.

Print Friendly, PDF & Email